Extended-release pramipexole in early Parkinson disease
Extended-release pramipexole in early Parkinson disease
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Innsbruck, AT · Author affiliation
From the Innsbruck Medical University (W.P.), Innsbruck, Austria; Clinical Investigation Center, INSERM CIC-9203 and UMR-825 and Departments of Clinical Pharmacology and Neurosciences (O.R.), Toulouse University Hospital, Toulouse, France; Università di Napoli Federico II-IDC Hermitage Capodimonte (P.B.), Naples, Italy; University of South Florida College of Medicine (R.A.H.), Tampa, FL; Juntendo University School of Medicine (Y.M.), Tokyo, Japan; Boehringer Ingelheim Pharma RCV GmbH & Co. KG (M...Location evidence
Toulouse, FR · Author affiliation
From the Innsbruck Medical University (W.P.), Innsbruck, Austria; Clinical Investigation Center, INSERM CIC-9203 and UMR-825 and Departments of Clinical Pharmacology and Neurosciences (O.R.), Toulouse University Hospital, Toulouse, France; Università di Napoli Federico II-IDC Hermitage Capodimonte (P.B.), Naples, Italy; University of South Florida College of Medicine (R.A.H.), Tampa, FL; Juntendo University School of Medicine (Y.M.), Tokyo, Japan; Boehringer Ingelheim Pharma RCV GmbH & Co. KG (M...Location evidence
Naples, IT · Author affiliation
From the Innsbruck Medical University (W.P.), Innsbruck, Austria; Clinical Investigation Center, INSERM CIC-9203 and UMR-825 and Departments of Clinical Pharmacology and Neurosciences (O.R.), Toulouse University Hospital, Toulouse, France; Università di Napoli Federico II-IDC Hermitage Capodimonte (P.B.), Naples, Italy; University of South Florida College of Medicine (R.A.H.), Tampa, FL; Juntendo University School of Medicine (Y.M.), Tokyo, Japan; Boehringer Ingelheim Pharma RCV GmbH & Co. KG (M...Location evidence
Tokyo, JP · Author affiliation
From the Innsbruck Medical University (W.P.), Innsbruck, Austria; Clinical Investigation Center, INSERM CIC-9203 and UMR-825 and Departments of Clinical Pharmacology and Neurosciences (O.R.), Toulouse University Hospital, Toulouse, France; Università di Napoli Federico II-IDC Hermitage Capodimonte (P.B.), Naples, Italy; University of South Florida College of Medicine (R.A.H.), Tampa, FL; Juntendo University School of Medicine (Y.M.), Tokyo, Japan; Boehringer Ingelheim Pharma RCV GmbH & Co. KG (M...Location evidence
A plain-language reading has not been prepared for this paper yet.